Skip to content

Efficacy of Intermittent Enteral Nutrition Versus Continuous Administration in Intensive Care

Efficacy of Intermittent Enteral Nutrition Versus Continuous Administration in Intensive Care Patients for the Reduction of Complications. Randomized Clinical Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05879263
Acronym
ENINCO
Enrollment
190
Registered
2023-05-30
Start date
2022-02-10
Completion date
2024-04-30
Last updated
2023-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Care, Enteral Nutrition, Feeding Methods, Gastric Feeding Tube

Keywords

Gastric Emptying, Diarrea, Vomiting, Respiratory Aspiration of Gastric Content, Caloric Intake, Enteral nutrition, Critical care

Brief summary

The goal of this clinical trial is to Determine efficacy of intermittent enteral nutrition vs continuous enteral nutrition in adults patients with a nasogastric tube in a intensive care unit. The main question\[s\] it aims to answer are: * Reduction of gastrointestinal and respiratory complications * Evaluate the achievement of the caloric objective Informed consent will be requested from participants who meet the inclusion criteria. The participants will be randomized into two groups: control group (continuous enteral nutrition) or experimental group (intermittent enteral nutrition) Researchers will compare intermittent enteral nutrition vs continuous to see if there is a reduction in gastrointestinal and respiratory complications.

Interventions

OTHERINTERMITTENT ENTERAL NUTRITITION (IEN)

Administration of Enteral Nutriton (EN) by nasogastric tube in 4 bolus (24h): Duration of the infusion 1hour each shot, using an infusion pump.

OTHERCONTINUOS ENTERAL NUTRITITION (CEN)

Administration of Enteral Nutriton (EN) by nasogastric tube during 24 hours, using an infusion pump.

Sponsors

University of Castilla-La Mancha
CollaboratorOTHER
Complejo Hospitalario Universitario de Albacete
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Masking description

By the nature of the intervention(intermittent or continuous administration of enteral nutrition) is impossible to mask it to participats, care provider or investigators.

Intervention model description

The patients wil be allocated to expriemental group or control group using a simple randomization sequence. There is an allocation concealment using sealed opaque envelopes Duration: From February 2022 to complete sample number.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients admitted to ICU of University General Hospital of Albacete * Need for enteral nutrition by nasogastric tube in the first 48 hours * Signed informed consent

Exclusion criteria

* Insulin dependent diabetic patients * Abdominal surgery * Dire prognosis

Design outcomes

Primary

MeasureTime frameDescription
Respiratory Complicationsduring ICU stay (maximum 15 days)Respiratory aspiration of gastric content
Gastrointestinal Complicationsduring ICU stay (maximum 15 days)Digestive intolerance: Diarrhea, vomiting, increased gastric residual volume(GRV)

Secondary

MeasureTime frameDescription
Achievement of the caloric objectiveduring ICU stay (up to 15 days)Time in hours to reach caloric goal
Nutritional status: MNAup to two days after admission to the ICUMeasure with:Mini Nutritional Assessment,(MNA) 12-14 points: Normal nutritional status 8-11 points: risk of malnutrition 0-7 points: Malnutrition
Changes in blood glucoseduring ICU stay (maximum 15 days)Episodes of hypoglycemia or hyperglycemia
ICU StayFrom date of randomization until 100 monthsDays of stay in ICU
Mortalityuntil the date of death from any cause until 100 monthsPercentage of deaths in ICU
Change of type of EN administrationduring ICU stay (maximum 15 days)Change of EN administration modality
Nutritional status:Glim Criteriaup to two days after admission to the ICUMeasure with: Glim criteria: Phenotypic criteria:Non-volitional weight loss (%) Low BMI (kg/m2)Reduced muscle mass(calf circumference (cm)) Etiologic criteria: Reduced food intake or assimilation. Inflammation \*Requires at least one phenotypic criterion and one etiologic criterion for the diagnosis of malnutrition
Nutritional status: Biochemical valuesup to two days after admission to the ICUMeasure with:biochemical values: albumin, prealbumin, total protein

Countries

Spain

Contacts

Primary ContactM.Dolores Saiz-Vinuesa, NURSE
tebisama@hotmail.com0034967597100
Backup ContactM.Pilar Córcoles-Jimenez, NURSE
pcorcoles@sescam.org0034967597169

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026